$3.94
-0.20-4.83%
Last update: Oct 23, 6:07 PM
Coya Therapeutics Inc (COYA) Stock Price, Quote, News & History
COYANASDAQ
Coya's COYA 303 showed strong immune modulation and reduced inflammation in the brain, supporting its development for neurodegenerative diseases like...
You can purchase shares of Coya Therapeutics (NASDAQ:COYA) through any online brokerage.
Other companies in Coya Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Coya Therapeutics has a consensus price target of $15.57.
The stock price for Coya Therapeutics (NASDAQ: COYA) is $3.9249 last updated October 23, 2026 at 6:07 PM EDT.
There are no upcoming dividends for Coya Therapeutics.
Coya Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Coya Therapeutics.
Coya Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative,...
